Peter Siesjö
21 – 30 of 94
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Sequestering of damage-associated molecular patterns (DAMPs) : a possible mechanism affecting the immune-stimulating properties of aluminium adjuvants
(
- Contribution to journal › Article
- 2016
-
Mark
A Patient-Assessed Morbidity to Evaluate Outcome in Surgically Treated Vestibular Schwannomas
(
- Contribution to journal › Article
-
Mark
Hearing and Vestibular Function After Preoperative Intratympanic Gentamicin Therapy for Vestibular Schwanomma as Part of Vestibular Prehab
(
- Contribution to journal › Article
-
Mark
Preoperative systemic levels of VEGFA, IL-7, IL-17A, and TNF-β delineate two distinct groups of children with brain tumors
(
- Contribution to journal › Article
- 2015
-
Mark
Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance.
(
- Contribution to journal › Article
-
Mark
A standardized and reproducible protocol for serum-free monolayer culturing of primary paediatric brain tumours to be utilized for therapeutic assays.
(
- Contribution to journal › Article
-
Mark
Al adjuvants can be tracked in viable cells by lumogallion staining.
(
- Contribution to journal › Article
-
Mark
Aberrant immunostaining pattern of the CD24 glycoprotein in clinical samples and experimental models of pediatric medulloblastomas.
(
- Contribution to journal › Article
- 2014
-
Mark
Unequivocal identification of intracellular aluminium adjuvant in a monocytic THP-1 cell line.
(
- Contribution to journal › Article
-
Mark
Long-term Mobile Phone Use and Acoustic Neuroma Risk.
(
- Contribution to journal › Article